Monday, May 10, 2021

New webinar: "Regulatory B cells and gut-microbiota: an intricate acting balance in autoimmunity"

9:00 AM to 10:00 AM

Bregs are provided in the gut-associated lymphoid tissue (GALT) as a result of the interaction between the gut microbiota and the innate immune system (Rosser et al., 2014). Mice depleted of endogenous bacteria following administration of broad-spectrum antibiotics do not develop arthritis or Bregs, suggesting an intricate relationship between the microbiota, inflammation, and Breg differentiation (Rosser et al., 2014). The question of whether inflammatory signals produced in response to the microbiota control Breg development alone or whether microbial factors also play a direct role remains unanswered.

Claudia Mauri will discuss how  butyrate supplementation suppresses arthritis in a Breg-dependent manner by increasing the level of the serotonin-derived metabolite 5-Hydroxyindole-3-acetic acid (5-HIAA), which activates the aryl-hydrocarbon receptor (AhR), a newly discovered transcriptional marker for Breg function.  

Presenter
Claudia Mauri is Professor of Immunology and Vice-Dean International of the Faculty Medical Science at University College in London. She received her Doctor of Biology with magna cum laude in 1989 and PhD equivalent in 1996 from the University La Sapienza in Rome, Italy. She performed postdoctoral work in London at The Kennedy Institute of Rheumatology, Imperial College, UK. She moved to University College London in 2002 where she established her group. Her main research interest lies in understanding how the microbiota and microbiota-derived metabolites drives the differentiation of regulatory B cells in autoimmunity.